tradingkey.logo

Helius Medical Technologies Inc

HSDT
2.190USD
+0.260+13.47%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
88.26MMarktkapitalisierung
VerlustKGV TTM

Helius Medical Technologies Inc

2.190
+0.260+13.47%

mehr Informationen über Helius Medical Technologies Inc Unternehmen

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Helius Medical Technologies Inc Informationen

BörsenkürzelHSDT
Name des UnternehmensSolana Co
IPO-datumJun 27, 2014
CEOAndreeff (Dane C)
Anzahl der mitarbeiter21
WertpapierartOrdinary Share
GeschäftsjahresendeJun 27
Addresse642 Newtown Yardley Road
StadtNEWTOWN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl18940
Telefon12159446100
Websitehttps://heliusmedical.com/
BörsenkürzelHSDT
IPO-datumJun 27, 2014
CEOAndreeff (Dane C)

Führungskräfte von Helius Medical Technologies Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-1.00%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-1.00%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Canada
26.00K
60.47%
Other revenue
10.00K
23.26%
United States
7.00K
16.28%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Mon, Feb 2
Aktualisiert: Mon, Feb 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
Andere
56.70%
Aktionäre
Aktionäre
Anteil
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
Andere
56.70%
Aktionärstypen
Aktionäre
Anteil
Corporation
26.51%
Hedge Fund
12.85%
Investment Advisor
11.57%
Investment Advisor/Hedge Fund
2.29%
Research Firm
0.06%
Individual Investor
0.02%
Andere
46.71%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
40
11.05M
26.76%
+1.08M
2025Q3
24
3.90M
10.09%
+3.90M
2025Q2
37
12.45K
1.83%
+11.99K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fusion Summer Ltd
6.83M
16.54%
-1.00
-0.00%
Oct 01, 2025
Pantera Capital Partners LP
3.90M
9.44%
-3.88M
-49.87%
Oct 01, 2025
Solana Rocket Holdings Ltd
3.89M
9.41%
--
--
Oct 01, 2025
Polar Asset Management Partners Inc.
2.18M
5.28%
-1.00
-0.00%
Oct 01, 2025
Aristeia Capital, L.L.C.
1.09M
2.64%
+1.09M
--
Sep 30, 2025
Citadel Advisors LLC
728.86K
1.76%
+728.86K
--
Sep 30, 2025
Ghisallo Capital Management LLC
726.64K
1.76%
+726.64K
--
Sep 30, 2025
VR Capital Group Ltd
581.31K
1.41%
+581.31K
--
Sep 30, 2025
Hel Ved Capital Management Limited
435.98K
1.06%
+435.98K
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
KeyAI